Company Number: 13167263

Analysis Date: 2025-07-29 21:03 UTC

Financial Health Assessment for LUGENCO LTD

---

1. Financial Health Score: D

Explanation:
LUGENCO LTD’s financial statements reveal concerning signs of financial distress, notably negative net current assets and net liabilities (negative net assets) for two consecutive years. This indicates the company is operating with a deficit in working capital and overall net worth, a symptom akin to a patient showing signs of "internal financial stress." While the company remains active and compliant with filing requirements, the balance sheet position signals risk that requires immediate attention.

---

2. Key Vital Signs (Financial Metrics & Interpretation)

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Current Assets	511	7	Slight increase but very low liquidity; cash and receivables are minimal, indicating weak "cash flow pulse."
Current Liabilities	990	3,391	Reduction in short-term debts but still nearly double current assets, indicating short-term obligations exceed liquid resources.
Net Current Assets	-479	-3,384	Negative working capital ("symptom of liquidity distress"), risking inability to meet immediate debts.
Net Assets (Equity)	-479	-3,384	Negative shareholders’ funds; company is technically insolvent on a balance sheet basis.
Share Capital	1.00	1.00	Minimal invested capital, reflecting limited financial "immune system" to absorb shocks.
Employee Count	1	1	Micro entity with minimal staffing, limiting operational scale and flexibility.

---

3. Diagnosis

LUGENCO LTD exhibits clear symptoms of financial distress:

• Negative Working Capital: The company’s current liabilities exceed its current assets by £479 in 2024, though this is a significant improvement from 2023’s £3,384 deficit. This indicates liquidity problems, meaning the company may struggle to pay bills and short-term obligations on time.

• Negative Net Assets: The company’s total liabilities exceed total assets, resulting in negative equity. This is a critical sign that the company’s financial "vital organs" (assets) are insufficient to cover all debts, a serious "health condition" that might threaten survival without intervention.

• Minimal Capital Base: Share capital is only £1.00, indicating very limited initial funding and low financial reserves.

• No Audit Requirement: Being a micro-entity, LUGENCO LTD benefits from simplified reporting but this also means less external scrutiny, potentially masking deeper issues.

• Operational Scale: With only one employee and minimal assets, the company is small and potentially vulnerable to market or operational shocks.

In summary, LUGENCO LTD’s financial health is fragile and shows symptoms consistent with a company under financial strain. However, the improvement in net current assets from 2023 to 2024 suggests some recovery efforts or operational adjustments.

---

4. Recommendations

To improve financial wellness and stabilize the company’s financial condition, the following actions are advised:

• Improve Liquidity Position:

  • Seek to increase current assets, particularly cash reserves. This could be through improved receivables collection, inventory management, or short-term financing.
  • Negotiate extended payment terms with creditors to ease immediate cash outflows.

• Capital Injection:

  • Consider additional share capital or loans from shareholders or third parties to strengthen the balance sheet and provide a financial buffer.

• Cost Control and Revenue Growth:

  • With only one employee, operational costs are likely low, but focus should be on generating consistent revenue streams and managing expenses tightly.

• Regular Financial Monitoring:

  • Implement monthly cash flow forecasting and financial reviews to detect early signs of distress and adjust plans accordingly.

• Professional Advice:

  • Engage with a financial advisor or accountant specializing in micro-entities to develop a turnaround plan.

• Compliance and Transparency:

  • Maintain timely filings and transparent reporting to build stakeholder confidence.

---